SeaCrest Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.3M | Sell |
13,553
-234
| -2% | -$239K | 1.8% | 9 |
|
|
2026
Q1 | $12.7M | Sell |
13,787
-163
| -1% | -$165K | 1.36% | 10 |
|
|
2025
Q4 | $15.5M | Buy |
13,950
+54
| +0.4% | +$51.6K | 1.56% | 10 |
|
|
2025
Q3 | $11.8M | Sell |
13,896
-212
| -2% | -$158K | 1.24% | 12 |
|
|
2025
Q2 | $11M | Sell |
14,108
-1,932
| -12% | -$1.5M | 1.19% | 12 |
|
|
2025
Q1 | $13.2M | Sell |
16,040
-524
| -3% | -$436K | 1.5% | 9 |
|
|
2024
Q4 | $12.8M | Sell |
16,564
-113
| -0.7% | -$93.6K | 1.34% | 12 |
|
|
2024
Q3 | $14.8M | Sell |
16,677
-3
| -0% | -$2.7K | 1.59% | 7 |
|
|
2024
Q2 | $15.1M | Sell |
16,680
-1,297
| -7% | -$1.04M | 1.72% | 7 |
|
|
2024
Q1 | $14M | Sell |
17,977
-2,325
| -11% | -$1.65M | 1.71% | 7 |
|
|
2023
Q4 | $12.6M | Buy |
20,302
+1,065
| +6% | +$622K | 1.55% | 7 |
|
|
2023
Q3 | $10.3M | Sell |
19,237
-31
| -0.2% | -$16K | 1.34% | 9 |
|
|
2023
Q2 | $9.04M | Buy |
19,268
+264
| +1% | +$111K | 1.14% | 10 |
|
|
2023
Q1 | $6.53M | Buy |
19,004
+686
| +4% | +$231K | 0.88% | 14 |
|
|
2022
Q4 | $6.7M | Buy |
18,318
+2,956
| +19% | +$1.05M | 0.96% | 13 |
|
|
2022
Q3 | $4.97M | Sell |
15,362
-1,420
| -8% | -$450K | 0.75% | 21 |
|
|
2022
Q2 | $5.44M | Buy |
16,782
+310
| +2% | +$93.1K | 0.68% | 21 |
|
|
2022
Q1 | $4.72M | Sell |
16,472
-503
| -3% | -$129K | 0.54% | 30 |
|
|
2021
Q4 | $4.69M | Buy |
16,975
+42
| +0.2% | +$10.6K | 0.51% | 32 |
|
|
2021
Q3 | $3.91M | Buy |
16,933
+295
| +2% | +$72.8K | 0.47% | 41 |
|
|
2021
Q2 | $3.82M | Buy |
16,638
+302
| +2% | +$60.7K | 0.46% | 42 |
|
|
2021
Q1 | $3.05M | Sell |
16,336
-329
| -2% | -$64.4K | 0.4% | 51 |
|
|
2020
Q4 | $2.81M | Buy |
16,665
+755
| +5% | +$113K | 0.4% | 49 |
|
|
2020
Q3 | $2.35M | Buy |
15,910
+47
| +0.3% | +$7.27K | 0.38% | 53 |
|
|
2020
Q2 | $2.6M | Sell |
15,863
-899
| -5% | -$138K | 0.45% | 50 |
|
|
2020
Q1 | $2.33M | Sell |
16,762
-263
| -2% | -$36.1K | 0.5% | 45 |
|
|
2019
Q4 | $2.24M | Buy |
17,025
+1,422
| +9% | +$165K | 0.38% | 64 |
|
|
2019
Q3 | $1.75M | Buy |
15,603
+1,109
| +8% | +$123K | 0.33% | 71 |
|
|
2019
Q2 | $1.61M | Sell |
14,494
-38
| -0.3% | -$4.47K | 0.33% | 71 |
|
|
2019
Q1 | $1.89M | Sell |
14,532
-305
| -2% | -$37.1K | 0.32% | 61 |
|
|
2018
Q4 | $1.72M | Sell |
14,837
-2,531
| -15% | -$283K | 0.35% | 55 |
|
|
2018
Q3 | $1.86M | Sell |
17,368
-94
| -0.5% | -$9.4K | 0.32% | 61 |
|
|
2018
Q2 | $1.49M | Buy |
17,462
+28
| +0.2% | +$2.3K | 0.27% | 74 |
|
|
2018
Q1 | $1.35M | Sell |
17,434
-825
| -5% | -$66.4K | 0.25% | 87 |
|
|
2017
Q4 | $1.54M | Buy |
+18,259
| New | +$1.55M | 0.28% | 67 |
|
Other funds holding LLY
SeaCrest Wealth Management's LLY Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2026, selling an estimated $239K and leaving 13,553 shares worth $16.3M. The position accounts for 1.8% of the portfolio, ranked #9.
SeaCrest Wealth Management first reported a position in LLY in Q4 2017 and has held it in 35 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- SeaCrest Wealth Management held 13,553 shares of Eli Lilly worth $16.3M as of Q2 2026.
- SeaCrest Wealth Management sold 234 Eli Lilly shares in Q2 2026, an estimated $239K.
- Eli Lilly made up 1.8% of SeaCrest Wealth Management's portfolio in Q2 2026, its #9 holding.
- SeaCrest Wealth Management first reported a position in Eli Lilly in Q4 2017 and has held it in 35 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.